The Council is actively engaged in generating several important scientific statements affecting clinical practice. These include: (1) recommendations for blood pressure measurement in humans (published January 2005); (2) recommendations for blood pressure measurement in animals (published in February 2005); (3) sleep apnea and cardiovascular disease: implications and management; (4) detection of chronic kidney disease in patients with cardiovascular disease; and (5) prevention and treatment of cardiovascular disease in patients with chronic kidney disease. In addition, we are planning scientific statements on (1) the treatment of hypertension in the prevention and management of ischemic heart disease and (2) the identification and management of resistant hypertension.
For the first time, the Council has conducted a continuing medical education program for practicing physicians on hypertension. This was a one-day meeting in New Orleans in November 2004, I wish each of you a most productive year and look forward to seeing you in Washington, DC, this fall. A brief aside about the BBO method (blood cascades over rat stomach strip, rat colon and chick rectum) for detection of circulating prostaglandins. On presenting our findings with the BBO method (we identified the renal vasculature as a critical site of RASprostaglandin interactions), many important scientific eyes of the American Scientific Establishment rolled up into their sockets, registering the view that these studies are low-tech, if not unscientific, something akin to alchemy. The studies of John Vane and colleagues at the Royal College of Surgeons as well as our own, gave testimony to the triumph of the intellect over technology (ideas trump gadgetry). This is not to say that high-tech was irrelevant to pursuing our scientific objectives; rather, it wasn't available. Moreover, the use of a bioassay technique, which registers the time course of changes in biologically active substances in the circulation, provides a "real-time picture" of the hormonal system under study in a dynamic manner. A splendid example of the versatility of the BBO method is found in John Vane's Gaddum Lecture of 1968 1 , which addressed the lung as a metabolic organ that both activated and inactivated key hormonal systems involving amines, peptides, and prostaglandins. These studies established the lung as much more than a gasbag and altered our perception of the vital contribution of the lung as both a modulator, terminator, and generator of circulating hormones.
C o u n c i l o n
Our scientific careers require periods of deep thought, and we do our best to avoid these demands. However, opportunities arise to escape the awful prospect of a life in which thinking is essential.
For those of us who are disinclined to thought, a career in either the dean's office or in industry beckons. "There is no expedient to which a man will not resort to avoid the real labor of thinking." (Joshua Reynolds, the 18th century English portrait painter) Science offers the opportunity to continue the preoccupations of childhood. For those who are reluctant to give up their toys, a career in science is recommended. Alexander Fleming said as much concerning the discovery of penicillin, "I was just playing about." The English physiologist Starling described research as "the greatest game on earth." This method, if indeed letting the imagination run wild can be considered methodical, provides the fuel for discoveries. It is the essence of the Dionysian approach to problem-solving and draws heavily on intuition, guessing, day-dreaming -in brief, the stuff of children's games. Chance and intuition are far more important than reason and logic. Worse, what passes as reason has been used to maintain traditional views and oppose new discoveries. Yet, it is precisely that mental faculty, sweet reason, and its implementation, the well-reasoned grant that the Review Committees at the National Institutes of Health hold in highest esteem. I turn to that most difficult passage in our scientific careers, writing Research Grants. I recently addressed, once again, this most onerous and necessary of activities. Like drug discovery, grant writing resembles the contest between the Trojan priest, Laocoön, and the serpents which beset him and his sons for incurring the wrath of the gods.
The Hungarian scientist and Nobel Laureate, Szent-Györgyi, said it well, based on the Nietzschean dichotomy, Apollo vs. Dionysius: "In science the Apollonian tends to develop established lines to perfection, while the Dionysian rather relies on intuition and is more likely to open new, unexpected alleys for research" 2 . Discoveries are the way of Dionysius, the god of wine, not
Save the Dates

Workshop at the Annual Fall meeting of the Council for High Blood Pressure Research
This year's workshop on Sept. 21 is being organized by Gabby Navar. The title is "Emerging Concepts on Neural Interactions in Hypertension." This area of research is extremely important to our understanding of the development of hypertension and recently there have been several significant advancements.
Hypertension Summer School
The Council for High Blood Pressure Research's 5th Hypertension Summer School will be held July 16-20 this year in Castine, Maine. This is an excellent opportunity for young investigators, students and fellows to learn the newest concepts in our understanding of hypertension and socialize with leaders in the field.
For conference information, go to www.americanheart.org/conferences or e-mail scientificonferences@heart.org. And now a message to Study Sections regarding their favorite descriptive phrases, fishing expeditions and focus:
1) The Portuguese word for research is "pesquisas," meaning "fishing."
2) To quote Julia M. In her Lewis K. Dahl Memorial Lecture, Dr. Touyz addressed the cellular and molecular mechanisms that lead to changes in vascular smooth muscle cells caused by hypertension. Among the many factors involved, Ang II appears to be one of the most important. Ang II, a multifunctional peptide with pleiotropic actions, modulates vasomotor tone through its vasoconstrictor effects, it regulates cell growth and apoptosis/anoikis, it influences cell migration and extracellular matrix deposition, it is proinflammatory and it stimulates production of growth factors and vasoactive agents. These effects are mediated via complex intracellular signaling pathways. Ang II induces many of its (patho)physiological effects by stimulating reactive oxygen species that influence downstream signaling molecules. Although there has been major progress in the elucidation of Ang II-mediated signaling, little is known about specific molecules underlying aberrant signaling in hypertension. Dr. Touyz's work has suggested that c-Src is a putative candidate because it is rapidly activated by Ang II and because it is a common upstream modulator to multiple Ang II-stimulated signaling pathways. Targeting such molecules/pathways could prevent or regress vascular damage, thereby potentially improving outcome in hypertension, a major cause of cardiovascular morbidity and mortality.
